« Return to News | CROs/Service Providers

ICON's DOCS expands with four new offices in Europe

Wednesday, November 16, 2011 10:11 AM

ICON's resourcing division, DOCS, has expanded in Europe by opening four new offices: in Milan, Italy; Budapest, Hungary; Brussels, Belgium and Berlin, Germany. This latest expansion brings the total number of DOCS offices in Europe to 22.

DOCS has been operational in Europe for over 15 years, growing from a small healthcare staffing business to a global provider of resourcing solutions, including functional service provision, strategic sourcing and permanent placement. DOCS’ European expansion follows its launch in Asia-Pacific in early 2011 and it plans to further expand in other key markets, including Latin America, Eastern Europe, the Middle East and Russia, in 2012.

“DOCS has always been strong in Europe and we have a large client and candidate base in the region,” commented Mr. Colin Stanley, president, DOCS.  “Investing in local support and infrastructure will ensure that we support the current and future needs of both clients and candidates. We have aggressive growth plans for the future and will continue our market expansion in line with these plans.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.